<p>根據 MarketBeat.com 的報道，目前覆蓋 Intuitive Surgical, Inc.（納斯達克代碼：ISRG - 獲取免費報告）的 26 位分析師對該公司的平均推薦為 “適度買入”。一位股票研究分析師給予該股票賣出評級，七位分析師給予持有評級，十八位分析師給予買入評級。在過去一年中，發佈報告的分析師對該股票的平均 12 個月目標價格為 581.9130 美元。</p>
<p>獲取 <strong>Intuitive Surgical</strong> 的提醒：</p>
<ul>
<li>Intuitive Surgical 的拋售為 30% 的反彈機會鋪平了道路</li>
</ul>
<p>ISRG 已成為多份研究分析師報告的主題。花旗集團在 3 月 11 日的報告中將 Intuitive Surgical 的評級從 “中性” 上調至 “買入”，並設定 590.00 美元的目標價格。TD Cowen 在 4 月 22 日的報告中將 Intuitive Surgical 的目標價格從 660.00 美元下調至 585.00 美元，並給予該股票 “買入” 評級。華爾街 Zen 在週六的報告中將 Intuitive Surgical 的評級從 “持有” 上調至 “買入”。摩根大通在 4 月 22 日的研究報告中將 Intuitive Surgical 的目標價格從 625.00 美元下調至 550.00 美元，並給予該公司 “增持” 評級。最後，Argus 在 2 月 4 日的研究報告中將 Intuitive Surgical 的目標價格從 630.00 美元下調至 560.00 美元，並給予該公司 “買入” 評級。</p>
<p><strong>查看我們關於 ISRG 的最新研究報告</strong></p>
<h2>內部人士下注</h2>
<ul>
<li>5 只股票在 AI 推動下加速上漲</li>
</ul>
<p>在相關消息中，董事 Amy L. Ladd 在 4 月 28 日的交易中出售了 500 股該股票。該股票以平均價格 473.46 美元出售，總價值為 236,730.00 美元。交易完成後，該董事在公司持有 239 股，價值 113,156.94 美元。此交易代表其持倉減少了 67.66%。該交易已在向 SEC 提交的文件中披露，文件可通過 SEC 網站訪問。該交易是在預先安排的 10b5-1 交易計劃下執行的。此外，SVP Patricia L. Wadors 在 2 月 27 日的交易中出售了 220 股該股票。該股票以平均價格 499.71 美元出售，總價值為 109,936.20 美元。此銷售的 SEC 文件提供了更多信息。在過去三個月中，內部人士共出售了價值 2,760,359 美元的 5,647 股公司股票。公司內部人士持有公司股票的 0.60%。</p>
<h2>對 Intuitive Surgical 的對沖基金看法</h2>
<p>對沖基金和其他機構投資者最近調整了對該股票的持有。Ashford Capital Management Inc.在第一季度將其在 Intuitive Surgical 的持倉增加了 8.9%。Ashford Capital Management Inc.現在持有 7,777 股該醫療設備提供商的股票，價值 3,585,000 美元，此前在此期間又購買了 634 股。KCM Investment Advisors LLC 在第一季度將其在 Intuitive Surgical 的持倉增加了 7.4%。KCM Investment Advisors LLC 現在持有 1,819 股該醫療設備提供商的股票，價值 839,000 美元，此前在此期間又購買了 125 股。Glen Eagle Advisors LLC 在第一季度將其在 Intuitive Surgical 的持倉增加了 8.2%。Glen Eagle Advisors LLC 現在持有 345 股該醫療設備提供商的股票，價值 159,000 美元，此前在此期間又購買了 26 股。Quantinno Capital Management LP 在第一季度將其在 Intuitive Surgical 的持倉增加了 18.1%。Quantinno Capital Management LP 現在持有 224,448 股該醫療設備提供商的股票，價值 103,469,000 美元，此前在此期間又購買了 34,445 股。最後，Owl Creek Asset Management L.P.在第一季度獲得了 Intuitive Surgical 的新股份，價值約 7,869,000 美元。機構投資者和對沖基金持有公司 83.64% 的股票。</p>
<h2>Intuitive Surgical 股票下跌 1.6%</h2>
<ul>
<li>超越生物技術——3 只面向成長型投資者的醫療股票</li>
</ul>
<p>納斯達克：ISRG 週五開盤價為 421.12 美元。該公司的 50 日移動平均價格為 463.63 美元，200 日移動平均價格為 514.04 美元。該公司的市值為 1491.4 億美元，市盈率為 51.04，PEG 比率為 3.36，貝塔值為 1.51。Intuitive Surgical 的 52 周低點為 417.74 美元，52 周高點為 603.88 美元。</p>
<p>Intuitive Surgical（納斯達克：ISRG - 獲取免費報告）最後一次發佈財報是在 4 月 21 日，醫療設備提供商報告每股收益（EPS）為 2.50 美元，超出分析師一致預期的 2.08 美元，超出幅度為 0.42 美元。該公司在本季度的收入為 27.7 億美元，而分析師預期為 26.2 億美元。Intuitive Surgical 的股本回報率為 15.98%，淨利潤率為 28.15%。與去年同期相比，Intuitive Surgical 的收入增長了 23.0%。在去年同期，該公司每股收益為 1.81 美元。賣方分析師預計 Intuitive Surgical 在當前年度將發佈 8.57 美元的每股收益。</p>
<h2>Intuitive Surgical 新聞摘要</h2>
<p>以下是本週影響 Intuitive Surgical 的主要新聞故事：</p>
<ul>
<li>積極情緒：多篇近期文章強調了直覺外科作為醫療保健人工智能繁榮的潛在受益者，認為每一次機器人手術都會產生有價值的數據，從而改善外科醫生培訓、術中指導和預測分析。手術機器人與人工智能的結合：直覺外科、美敦力和史崔克是醫療繁榮的潛在黑馬</li>
<li>積極情緒：Erste Group Bank 的分析師上調了對 ISRG 的 2026 財年和 2027 財年盈利預期，強化了盈利增長能夠持續超出市場共識的預期。MarketBeat 對 ISRG 的覆蓋</li>
<li>積極情緒：關於達芬奇 5 的報道指出手術增長強勁，系統利用率提高，表明該公司的最新平台仍在外科醫生和醫院中獲得認可。ISRG 的達芬奇 5 能否維持手術和利用率的增長？</li>
<li>中性情緒：幾篇樂觀的評論文章表示，近期的拋售使得直覺外科對成長型投資者更具吸引力，但這些主要是評論，而非新的公司特定催化劑。直覺外科今年已下跌 20%。華爾街表示現在是買入的時機。</li>
</ul>
<h2>關於直覺外科</h2>
<p>(獲取免費報告)</p>
<p>直覺外科成立於 1995 年，總部位於加利福尼亞州陽光谷，是一家專注於設計、製造和服務機器人輔助手術系統的醫療技術公司。該公司以其達芬奇手術系統而聞名，該系統通過將外科醫生的手部動作轉化為患者體內小型儀器的更精細、縮放的動作，從而實現微創手術。直覺的業務集中在向醫院和手術中心提供系統、儀器及相關技術，旨在提高手術室的精確度、可視化和控制能力。</p>
<p>除了核心手術平台外，直覺還銷售一系列可重複使用和一次性使用的儀器、配件和專有軟件，併為客户提供培訓、服務和臨牀支持。</p>
<h2>進一步閲讀</h2>
<ul>
<li>我們更看好的五隻股票，勝過直覺外科</li>
<li>如果油價持續上漲，值得擁有的三隻股票</li>
<li>分析師青睞的三家關鍵航空航天組件製造商</li>
<li>Alphabet 的 Googlebook 將 Gemini AI 帶入 PC 硬件</li>
<li>Peloton 股票在樂觀的財報後回吐漲幅</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="600" height="385" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在直覺外科嗎？</h2>
<p>在考慮直覺外科之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前買入……而直覺外科並不在名單上。</p>
<p>雖然直覺外科目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

直覺外科

標普健康醫療設備 ETF - SPDR

ISUL

美國醫藥設備 ETF - iShares

<p>直覺外科（Intuitive Surgical, Inc.）（納斯達克代碼：ISRG）獲得了 26 位分析師的 “適度買入” 共識評級。12 個月的平均目標價格為 581.91 美元，其中包括 18 個買入、7 個持有和 1 個賣出建議。最近注意到內部人士的股票出售和機構投資，內部人士在過去三個月內出售了 5,647 股，價值 276 萬美元。該股票開盤價為 421.12 美元，下跌 1.6%，市值為 1491.4 億美元，市盈率為 51.04</p>

<p>Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) have been given an average recommendation of &#34;Moderate Buy&#34; by the twenty-six analysts that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and eighteen have issued a buy recommendation on the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $581.9130.</p>
<div class="lb-trans"><p>根據 MarketBeat.com 的報道，目前覆蓋 Intuitive Surgical, Inc.（納斯達克代碼：ISRG - 獲取免費報告）的 26 位分析師對該公司的平均推薦為 “適度買入”。一位股票研究分析師給予該股票賣出評級，七位分析師給予持有評級，十八位分析師給予買入評級。在過去一年中，發佈報告的分析師對該股票的平均 12 個月目標價格為 581.9130 美元。</p>
</div><p>Get <strong>Intuitive Surgical</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Intuitive Surgical</strong> 的提醒：</p>
</div><ul>
<li>Intuitive Surgical's Selloff Sets Up a 30% Rebound Opportunity</li>
</ul>
<div class="lb-trans"><ul>
<li>Intuitive Surgical 的拋售為 30% 的反彈機會鋪平了道路</li>
</ul>
</div><p>ISRG has been the topic of a number of research analyst reports. Citigroup raised Intuitive Surgical from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and set a $590.00 target price on the stock in a report on Wednesday, March 11th. TD Cowen lowered their target price on Intuitive Surgical from $660.00 to $585.00 and set a &#34;buy&#34; rating on the stock in a report on Wednesday, April 22nd. Wall Street Zen raised Intuitive Surgical from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a report on Saturday. JPMorgan Chase &amp; Co. decreased their price target on Intuitive Surgical from $625.00 to $550.00 and set an &#34;overweight&#34; rating for the company in a research report on Wednesday, April 22nd. Finally, Argus decreased their price target on Intuitive Surgical from $630.00 to $560.00 and set a &#34;buy&#34; rating for the company in a research report on Wednesday, February 4th.</p>
<div class="lb-trans"><p>ISRG 已成為多份研究分析師報告的主題。花旗集團在 3 月 11 日的報告中將 Intuitive Surgical 的評級從 “中性” 上調至 “買入”，並設定 590.00 美元的目標價格。TD Cowen 在 4 月 22 日的報告中將 Intuitive Surgical 的目標價格從 660.00 美元下調至 585.00 美元，並給予該股票 “買入” 評級。華爾街 Zen 在週六的報告中將 Intuitive Surgical 的評級從 “持有” 上調至 “買入”。摩根大通在 4 月 22 日的研究報告中將 Intuitive Surgical 的目標價格從 625.00 美元下調至 550.00 美元，並給予該公司 “增持” 評級。最後，Argus 在 2 月 4 日的研究報告中將 Intuitive Surgical 的目標價格從 630.00 美元下調至 560.00 美元，並給予該公司 “買入” 評級。</p>
</div><p><strong>Check Out Our Latest Research Report on ISRG</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 ISRG 的最新研究報告</strong></p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>內部人士下注</h2>
</div><ul>
<li>5 Stocks Racing Ahead as AI Supercharges Robotics</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只股票在 AI 推動下加速上漲</li>
</ul>
</div><p>In related news, Director Amy L. Ladd sold 500 shares of the stock in a transaction on Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total value of $236,730.00. Following the completion of the transaction, the director owned 239 shares in the company, valued at $113,156.94. This trade represents a 67.66% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia L. Wadors sold 220 shares of the stock in a transaction on Friday, February 27th. The shares were sold at an average price of $499.71, for a total value of $109,936.20. The SEC filing for this sale provides additional information. Insiders have sold a total of 5,647 shares of company stock worth $2,760,359 over the last three months. Company insiders own 0.60% of the company's stock.</p>
<div class="lb-trans"><p>在相關消息中，董事 Amy L. Ladd 在 4 月 28 日的交易中出售了 500 股該股票。該股票以平均價格 473.46 美元出售，總價值為 236,730.00 美元。交易完成後，該董事在公司持有 239 股，價值 113,156.94 美元。此交易代表其持倉減少了 67.66%。該交易已在向 SEC 提交的文件中披露，文件可通過 SEC 網站訪問。該交易是在預先安排的 10b5-1 交易計劃下執行的。此外，SVP Patricia L. Wadors 在 2 月 27 日的交易中出售了 220 股該股票。該股票以平均價格 499.71 美元出售，總價值為 109,936.20 美元。此銷售的 SEC 文件提供了更多信息。在過去三個月中，內部人士共出售了價值 2,760,359 美元的 5,647 股公司股票。公司內部人士持有公司股票的 0.60%。</p>
</div><h2>Hedge Funds Weigh In On Intuitive Surgical</h2>
<div class="lb-trans"><h2>對 Intuitive Surgical 的對沖基金看法</h2>
</div><p>Hedge funds and other institutional investors have recently modified their holdings of the stock. Ashford Capital Management Inc. boosted its position in Intuitive Surgical by 8.9% during the 1st quarter. Ashford Capital Management Inc. now owns 7,777 shares of the medical equipment provider's stock worth $3,585,000 after acquiring an additional 634 shares during the period. KCM Investment Advisors LLC boosted its position in Intuitive Surgical by 7.4% during the 1st quarter. KCM Investment Advisors LLC now owns 1,819 shares of the medical equipment provider's stock worth $839,000 after acquiring an additional 125 shares during the period. Glen Eagle Advisors LLC boosted its position in Intuitive Surgical by 8.2% during the 1st quarter. Glen Eagle Advisors LLC now owns 345 shares of the medical equipment provider's stock worth $159,000 after acquiring an additional 26 shares during the period. Quantinno Capital Management LP boosted its position in Intuitive Surgical by 18.1% during the 1st quarter. Quantinno Capital Management LP now owns 224,448 shares of the medical equipment provider's stock worth $103,469,000 after acquiring an additional 34,445 shares during the period. Finally, Owl Creek Asset Management L.P. acquired a new stake in Intuitive Surgical during the 1st quarter worth about $7,869,000. Institutional investors and hedge funds own 83.64% of the company's stock.</p>
<div class="lb-trans"><p>對沖基金和其他機構投資者最近調整了對該股票的持有。Ashford Capital Management Inc.在第一季度將其在 Intuitive Surgical 的持倉增加了 8.9%。Ashford Capital Management Inc.現在持有 7,777 股該醫療設備提供商的股票，價值 3,585,000 美元，此前在此期間又購買了 634 股。KCM Investment Advisors LLC 在第一季度將其在 Intuitive Surgical 的持倉增加了 7.4%。KCM Investment Advisors LLC 現在持有 1,819 股該醫療設備提供商的股票，價值 839,000 美元，此前在此期間又購買了 125 股。Glen Eagle Advisors LLC 在第一季度將其在 Intuitive Surgical 的持倉增加了 8.2%。Glen Eagle Advisors LLC 現在持有 345 股該醫療設備提供商的股票，價值 159,000 美元，此前在此期間又購買了 26 股。Quantinno Capital Management LP 在第一季度將其在 Intuitive Surgical 的持倉增加了 18.1%。Quantinno Capital Management LP 現在持有 224,448 股該醫療設備提供商的股票，價值 103,469,000 美元，此前在此期間又購買了 34,445 股。最後，Owl Creek Asset Management L.P.在第一季度獲得了 Intuitive Surgical 的新股份，價值約 7,869,000 美元。機構投資者和對沖基金持有公司 83.64% 的股票。</p>
</div><h2>Intuitive Surgical Stock Down 1.6%</h2>
<div class="lb-trans"><h2>Intuitive Surgical 股票下跌 1.6%</h2>
</div><ul>
<li>Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>超越生物技術——3 只面向成長型投資者的醫療股票</li>
</ul>
</div><p>NASDAQ:ISRG opened at $421.12 on Friday. The business's 50-day moving average price is $463.63 and its 200 day moving average price is $514.04. The firm has a market cap of $149.14 billion, a P/E ratio of 51.04, a PEG ratio of 3.36 and a beta of 1.51. Intuitive Surgical has a 52-week low of $417.74 and a 52-week high of $603.88.</p>
<div class="lb-trans"><p>納斯達克：ISRG 週五開盤價為 421.12 美元。該公司的 50 日移動平均價格為 463.63 美元，200 日移動平均價格為 514.04 美元。該公司的市值為 1491.4 億美元，市盈率為 51.04，PEG 比率為 3.36，貝塔值為 1.51。Intuitive Surgical 的 52 周低點為 417.74 美元，52 周高點為 603.88 美元。</p>
</div><p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.08 by $0.42. The firm had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.Intuitive Surgical's revenue was up 23.0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.81 earnings per share. Sell-side analysts expect that Intuitive Surgical will post 8.57 EPS for the current year.</p>
<div class="lb-trans"><p>Intuitive Surgical（納斯達克：ISRG - 獲取免費報告）最後一次發佈財報是在 4 月 21 日，醫療設備提供商報告每股收益（EPS）為 2.50 美元，超出分析師一致預期的 2.08 美元，超出幅度為 0.42 美元。該公司在本季度的收入為 27.7 億美元，而分析師預期為 26.2 億美元。Intuitive Surgical 的股本回報率為 15.98%，淨利潤率為 28.15%。與去年同期相比，Intuitive Surgical 的收入增長了 23.0%。在去年同期，該公司每股收益為 1.81 美元。賣方分析師預計 Intuitive Surgical 在當前年度將發佈 8.57 美元的每股收益。</p>
</div><h2>Intuitive Surgical News Summary</h2>
<div class="lb-trans"><h2>Intuitive Surgical 新聞摘要</h2>
</div><p>Here are the key news stories impacting Intuitive Surgical this week:</p>
<div class="lb-trans"><p>以下是本週影響 Intuitive Surgical 的主要新聞故事：</p>
</div><ul>
<li>Positive Sentiment: Multiple recent articles highlighted Intuitive Surgical as a potential beneficiary of the AI boom in healthcare, arguing that every robotic procedure creates valuable data that can improve surgeon training, intraoperative guidance, and predictive analytics. Surgical Robotics Meets AI: Intuitive Surgical, Medtronic, and Stryker Are the Sleeper Plays of the Healthcare Boom</li>
<li>Positive Sentiment: Analysts at Erste Group Bank nudged up their FY2026 and FY2027 earnings estimates for ISRG, reinforcing expectations that earnings growth can continue above consensus. MarketBeat ISRG coverage</li>
<li>Positive Sentiment: Coverage around da Vinci 5 pointed to strong procedure growth and higher system utilization, suggesting the company’s newest platform is still gaining traction with surgeons and hospitals. Can ISRG's da Vinci 5 Momentum Sustain Procedure and Utilization Gains?</li>
<li>Neutral Sentiment: Several bullish opinion pieces said the recent selloff has made Intuitive Surgical look more attractive to growth investors, but these were mostly commentary rather than new company-specific catalysts. Intuitive Surgical Has Dropped 20% This Year. Wall Street Says It's Time to Buy.</li>
</ul>
<div class="lb-trans"><ul>
<li>積極情緒：多篇近期文章強調了直覺外科作為醫療保健人工智能繁榮的潛在受益者，認為每一次機器人手術都會產生有價值的數據，從而改善外科醫生培訓、術中指導和預測分析。手術機器人與人工智能的結合：直覺外科、美敦力和史崔克是醫療繁榮的潛在黑馬</li>
<li>積極情緒：Erste Group Bank 的分析師上調了對 ISRG 的 2026 財年和 2027 財年盈利預期，強化了盈利增長能夠持續超出市場共識的預期。MarketBeat 對 ISRG 的覆蓋</li>
<li>積極情緒：關於達芬奇 5 的報道指出手術增長強勁，系統利用率提高，表明該公司的最新平台仍在外科醫生和醫院中獲得認可。ISRG 的達芬奇 5 能否維持手術和利用率的增長？</li>
<li>中性情緒：幾篇樂觀的評論文章表示，近期的拋售使得直覺外科對成長型投資者更具吸引力，但這些主要是評論，而非新的公司特定催化劑。直覺外科今年已下跌 20%。華爾街表示現在是買入的時機。</li>
</ul>
</div><h2>About Intuitive Surgical</h2>
<div class="lb-trans"><h2>關於直覺外科</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.</p>
<div class="lb-trans"><p>直覺外科成立於 1995 年，總部位於加利福尼亞州陽光谷，是一家專注於設計、製造和服務機器人輔助手術系統的醫療技術公司。該公司以其達芬奇手術系統而聞名，該系統通過將外科醫生的手部動作轉化為患者體內小型儀器的更精細、縮放的動作，從而實現微創手術。直覺的業務集中在向醫院和手術中心提供系統、儀器及相關技術，旨在提高手術室的精確度、可視化和控制能力。</p>
</div><p>In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.</p>
<div class="lb-trans"><p>除了核心手術平台外，直覺還銷售一系列可重複使用和一次性使用的儀器、配件和專有軟件，併為客户提供培訓、服務和臨牀支持。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Intuitive Surgical</li>
<li>3 Stocks to Own If Gas Prices Keep Rising</li>
<li>3 Crucial Aerospace Component Makers That Analysts Love</li>
<li>Alphabet's Googlebook Brings Gemini AI to PC Hardware</li>
<li>Peloton Stock Gives Back Gains After Upbeat Earnings Report</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，勝過直覺外科</li>
<li>如果油價持續上漲，值得擁有的三隻股票</li>
<li>分析師青睞的三家關鍵航空航天組件製造商</li>
<li>Alphabet 的 Googlebook 將 Gemini AI 帶入 PC 硬件</li>
<li>Peloton 股票在樂觀的財報後回吐漲幅</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=ISRG"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Intuitive Surgical Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在直覺外科嗎？</h2>
</div><p>Before you consider Intuitive Surgical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮直覺外科之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前買入……而直覺外科並不在名單上。</p>
</div><p>While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然直覺外科目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Intuitive Surgical, Inc. (NASDAQ:ISRG) Given Consensus Rating of "Moderate Buy" by Brokerages

Market Beat

GraniteShares 2x Long ISRG Daily ETF

花旗

Toronto Dominion Bank

摩根大通

CITIGROUP INC 6.250 NON CUM SER II PFD WI

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Intuitive Surgical 公司（納斯達克股票代碼：ISRG）被券商一致給予 “適度買入” 評級